Cite
Assessment of dysarthria with Frenchay dysarthria assessment (FDA-2) in patients with Duchenne muscular dystrophy
MLA
Maki Ikezawa, et al. “Assessment of Dysarthria with Frenchay Dysarthria Assessment (FDA-2) in Patients with Duchenne Muscular Dystrophy.” Disability and Rehabilitation, vol. 44, no. 8, Aug. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....991f3425665cd4b47b82d94eaf347e21&authtype=sso&custid=ns315887.
APA
Maki Ikezawa, Tomoyoshi Otsuka, Michiyuki Kawakami, Meigen Liu, Yasuhiro Chiba, Miyuki Ito, Nanako Hijikata, Eri Fujino, Ayako Wada, & Kentaro Kaji. (2020). Assessment of dysarthria with Frenchay dysarthria assessment (FDA-2) in patients with Duchenne muscular dystrophy. Disability and Rehabilitation, 44(8).
Chicago
Maki Ikezawa, Tomoyoshi Otsuka, Michiyuki Kawakami, Meigen Liu, Yasuhiro Chiba, Miyuki Ito, Nanako Hijikata, Eri Fujino, Ayako Wada, and Kentaro Kaji. 2020. “Assessment of Dysarthria with Frenchay Dysarthria Assessment (FDA-2) in Patients with Duchenne Muscular Dystrophy.” Disability and Rehabilitation 44 (8). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....991f3425665cd4b47b82d94eaf347e21&authtype=sso&custid=ns315887.